Longboard Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Complete ESG assessment of Longboard Pharmaceuticals Inc can be reached by signing up for free. Alternative companies in the rating industry group for Longboard Pharmaceuticals Inc are shown. The webpage contains a Q&A section on Longboard Pharmaceuticals Inc.
Longboard Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 3.2 and governance score of 6.0.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | Longboard Pharmaceuticals Inc | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Longboard Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Longboard Pharmaceuticals Inc disclose current and historical energy intensity?
Does Longboard Pharmaceuticals Inc report the average age of the workforce?
Does Longboard Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Longboard Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Longboard Pharmaceuticals Inc disclose cybersecurity risks?
Does Longboard Pharmaceuticals Inc offer flexible work?
Does Longboard Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Longboard Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Longboard Pharmaceuticals Inc conduct supply chain audits?
Does Longboard Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Longboard Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Longboard Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Longboard Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Longboard Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Longboard Pharmaceuticals Inc disclose water use targets?
Does Longboard Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Longboard Pharmaceuticals Inc have a product recall in the last two years?
Does Longboard Pharmaceuticals Inc disclose incidents of discrimination?
Does Longboard Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Longboard Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Longboard Pharmaceuticals Inc disclose parental leave metrics?
Does Longboard Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Longboard Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Longboard Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Longboard Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Longboard Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Longboard Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Longboard Pharmaceuticals Inc involved in embryonic stem cell research?
Does Longboard Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Longboard Pharmaceuticals Inc disclose its waste policy?
Does Longboard Pharmaceuticals Inc report according to TCFD requirements?
Does Longboard Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Longboard Pharmaceuticals Inc disclose energy use targets?
Does Longboard Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Longboard Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Longboard Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.